Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Denosumab × Clear all

NCT03869762 2026-04-13

DICE

Phase 2 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

NCT02758132 2019-11-08

Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases

Phase 2 Terminated

1 enrolled 7 charts

Prostatic Neoplasms